Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense.

Boulant, Steeve; Forero, Adriana; Santer, Deanna M; Broggi, Achille

Boulant, Steeve; Forero, Adriana; Santer, Deanna M; Broggi, Achille.

Afiliação

Boulant S; Department of Molecular Genetics & Microbiology University of Florida, College of Medicine, Gainesville, FL, United States.
Forero A; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH, United States.
Santer DM; Infectious Diseases Institute, The Ohio State University, Columbus, OH, United States.
Broggi A; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.

Front Immunol ; 13: 1030812, 2022.

Article em En | MEDLINE | ID: mdl-36189214

Assuntos

Antivirais; Interferons; Hepacivirus; Interferon lambda

Palavras-chave

IBD; IFN-lambda; IFN-λ4; antiviral; infection; interferon; mucosae; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Interferons Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google